As a new-type foreign trade service provider driven by technological transformation and foreign trade business, HiSiaddi has built a "1+2+3+4=1" service system and can supply Copper Tripeptide-1 sourced directly from multiple well-known original manufacturers.
Boasting R&D capabilities, HiSiaddi frequently develops formula optimization solutions and application improvement suggestions for Copper Tripeptide-1 based on technological cooperation with manufacturers and precise market insight. Below is a consulting case of Copper Tripeptide-1 formula optimization delivered by HiSiaddi.
For more formula optimization consulting services, please contact HiSiaddi customer service.
The buyer, SwissDerma Biological Research Center based in Zurich, Switzerland, has specialized in high-end medical beauty raw material formulas for the Alpine region for 26 years, supplying over 300 specialist medical beauty institutions across Switzerland, Liechtenstein and Austria. All product lines hold EU SCCS safety certifications and Swiss ECOCERT organic certifications, with core product lines including post-procedure repair serums, dermal anti-wrinkle essences and sensitive-skin sterile ampoules. Copper Tripeptide-1 (GHK-Cu Blue Copper Peptide) acts as the flagship repair raw material of the brand, with an annual procurement volume of 5.8 tons divided into two specifications: 99.2% ultra-high-purity lyophilized powder and 5% beet-based organic stock solution.
This marked the client’s first procurement of domestic raw materials. After purchasing off-the-shelf raw materials from a leading domestic peptide enterprise, four major technical failures emerged in batches during finished essence blending after raw materials arrived at warehouses in Switzerland, stalling new product launches and threatening scrap losses for semi-finished products already in production. The client’s original formulas using original European copper tripeptide-1 (Sederma) delivered stable results, yet six consecutive trial batches using domestic raw materials failed completely. The raw material manufacturer only provided domestic standard COA reports without dedicated formulation application engineers, unable to troubleshoot technical root causes from both raw material and formulation perspectives. The client urgently entrusted HiSiaddi, a domestic technical foreign trade service provider, to conduct full-process technical diagnosis, formula optimization and production process rectification.
The repair essence formulated by the client turned from light blue to dark green after 15 days of ambient storage, with tiny precipitates forming locally. Third-party testing revealed the effective activity of copper tripeptide-1 plummeted from 98.1% at factory delivery to 57.3%, with free copper ions exceeding the internal control limit of 28ppm to 86ppm. The coordination bonds of raw materials fractured, resulting in loss of efficacy. Root cause: The domestic stock solution raw material lacked buffer system protection with excessive free copper impurities. The client’s original formula contained pure VC and witch hazel plant extracts; strong reducing ingredients underwent redox reactions with free copper, destroying the coordination structure of GHK-Cu.
The client’s essence formula adopted Carbomer 940 as the gel matrix. After adding copper tripeptide-1 stock solution, the originally viscous essence suffered a sharp viscosity drop within 3 hours with water separation and delamination, rendering it unfit for filling. Mechanism: Divalent copper ions in blue copper peptide act as cationic electrolytes, breaking the anionic polymer network structure of carbomer and dissociating the gel emulsion. The client’s formula followed the compounding logic of European raw materials, where original European blue copper peptide was pre-encapsulated with liposomes to avoid ionic interference, while conventional domestic raw materials had no encapsulation treatment.
In vitro Franz diffusion cell transdermal test data showed the transdermal rate of domestic raw materials only reached 18.7%, compared with 37.2% for original Sederma copper tripeptide-1. The dermal repair efficacy of finished products failed to meet clinical acceptance standards of Swiss medical beauty clinics, blocking offline salon channel access. Domestic raw materials are conventional water-soluble monomers without penetration-promoting modification, and their hydrophilic properties hinder penetration through the stratum corneum.
The client’s production line followed feeding logic for ordinary skincare raw materials, adding blue copper peptide stock solution during the high-temperature water phase stage at 85℃ emulsification. High temperatures directly triggered peptide chain hydrolysis and copper ion dissociation, resulting in over 30% instant activity loss upon feeding, putting the full 520kg batch of semi-finished stock solution at risk of scrapping.
HiSiaddi assembled a special technical team consisting of peptide raw material engineers, cosmetic formulators and production process engineers, coordinating raw material manufacturers and the Swiss client’s R&D laboratory simultaneously to implement rectifications one by one across raw material modification optimization, formula system reconstruction, auxiliary material selection and mass production process adjustment. All work was benchmarked against Swiss organic cosmetic regulations and the client’s clinical formulation indicators.
1. Purification & impurity removal for high-purity raw materials: Coordinated upstream manufacturers to upgrade the three-step ion exchange chromatography process for in-production copper tripeptide-1 batches, adding a chelating filtration section for free copper to strictly control free copper ions ≤25ppm and short peptide impurities <0.07%. Retested HPLC purity stably ≥99.2%. Industrial propylene glycol carriers were eliminated and fully replaced with EU-certified beet-fermented propylene glycol to remove trace aldehyde impurities (a trigger for discoloration);
2. Customized buffer-protected stock solution: A citric acid-phosphate composite buffer system was added to the 5% organic stock solution to lock the stock solution pH steadily at 5.6±0.2 (optimal stability range of blue copper peptide: 5.0~6.5), isolating structural damage caused by pH fluctuations in formulas. Accelerated testing at constant 60℃ for 45 days showed no discoloration and activity retention ≥93% for factory-delivered samples;
3. Development of two modified grades tailored to finished products: Raw material variants were split for the client’s two finished products: ①Stabilized blue copper peptide stock solution for conventional essences; ②Phospholipid pre-encapsulated modified blue copper peptide exclusive for ampoules, with low-degree lipid encapsulation completed at the factory in advance and vesicle particle size of 60~90nm to isolate copper ions from formula electrolytes.
1. Antioxidant system replacement to eliminate VC compatibility conflicts: Pure L-ascorbic acid (strong reducing agent) was removed from the formula and replaced with stable VC derivative AA2G (ascorbyl glucoside) to weaken redox reactions. Trace zinc hyaluronate was added for synergistic stabilization to build an internal antioxidant protection network in formulas and block oxidative discoloration of copper ions. The dosage of high-acid witch hazel extract was reduced, and buffer salts were used to fine-tune the final pH of finished products to 5.4~6.2 to avoid strong acid environments;
2. Thickening system replacement to resolve carbomer gel breakage and water separation: The single Carbomer 940 system was abandoned, replaced with associative acrylate thickeners compounded with plant polysaccharides. Non-ionic thickening matrices are immune to damage from copper ion electrolytes. Two fine-tuning schemes were provided for the client’s original formula framework: Scheme A (retain original formula structure) uses pre-encapsulated modified blue copper peptide; Scheme B (low-cost optimization) replaces thickening auxiliary materials. Both schemes passed three rounds of cold & hot cycle stability testing (-5℃~45℃ cycles for 90 days) without delamination or gel breakage;
3. Transdermal efficacy formula improvement: Penetration-promoting components compounded from hydrogenated lecithin and methyl gluceth-20 at a ratio of 1:8 were added to formulas to synergistically boost stratum corneum penetration with blue copper peptide. In vitro transdermal testing raised the rate from 18.7% to 38.1%, matching the level of original European imported raw materials.
1. Rectification of feeding nodes: Standardized low-temperature feeding specifications for blue copper peptide: add raw materials only after cooling the water phase to ≤38℃, strictly prohibiting addition during high-temperature emulsification. Lyophilized powder must be pre-dissolved slowly in buffered deionized water at low temperature before adding to the system, avoiding local complexation deactivation caused by excessively high local concentrations from direct dry powder feeding;
2. Light-shielding control for production: All blue copper peptide feeding and homogenization procedures are completed under light-shielded conditions, as UV radiation accelerates oxidative degradation of copper peptide. Light-blocking curtains were installed in workshops, and finished products adopt opaque brown vacuum bottles to eliminate discoloration risks during storage;
3. Graded homogenization parameter optimization: Homogenization rotation speeds were optimized into three stages: low-speed pre-mixing → medium-speed homogenization → low-speed defoaming, preventing high-speed shearing from destroying phospholipid encapsulation structures and guaranteeing vesicle integrity of encapsulated raw materials.
1. Laboratory small trials: HiSiaddi sent samples of modified raw materials paired with optimized formulas to Swiss laboratories. Three consecutive batches of accelerated stability testing (constant 45℃ for 3 months) showed no discoloration or precipitation in finished products, with activity retention ≥91%. Transdermal and in vitro collagen proliferation data all met standards;
2. 50kg pilot mass production: The client’s production line ran pilot batches following the new standards, with HiSiaddi providing real-time online guidance on feeding and temperature control. Pilot finished products were sent to Swiss third-party drug regulatory laboratories for testing and passed pre-review of Swiss ECOCERT organic raw material compatibility;
3. Full-batch switching of raw material supply: The remaining 5.3 tons of raw materials were produced and shipped in 6 batches following optimized modification standards, with each batch accompanied by raw material modification instructions, formula usage guidelines and feeding process specification manuals.
1. The prior 520kg batch of semi-finished products scheduled for scrapping was salvaged through fine-tuning of auxiliary material formulas for reworking and filling, reducing raw material losses of approximately 78,000 Swiss francs. New products passed Swiss drug regulatory filing on schedule and launched across all channel medical beauty institutions. Terminal sales volume of repair essences rose by 36.8% year-on-year in the first quarter after launch;
2. The comprehensive procurement cost of domestic modified blue copper peptide decreased by 31.6% compared with original European imported raw materials. A follow-up annual long-term order of 6.5 tons was signed, and HiSiaddi was entrusted to deliver technical matching services for two premium peptides: Acetyl Hexapeptide-8 and Copper Tripeptide-29.
Leveraging this technical rectification case for high-end Swiss clients, standardized production processes were developed for two premium copper tripeptide-1 grades: customized buffered stock solution and pre-encapsulated modified variants, forming internal control standards for export to European and American salon channels. Three additional customized orders from high-end skincare laboratories in Finland and Norway were secured subsequently, with export premiums for high-end modified grades rising by 32% and escape from low-price competition in generic bulk markets.
A one-stop peptide technical service system was established covering raw material defect diagnosis → raw material modification optimization → terminal formula reconstruction → mass production process delivery. A compatibility contraindication database for blue copper peptide and a library of formula adaptation schemes for clients from different regions were built, supporting subsequent technical matching services for mid-to-high-end cosmetic brands in Germany and France.
1. Insights for Overseas Mid-to-High-End Clients: Formulas of European and American organic salon skincare products feature far higher precision than mass-market daily chemical formulas. Any deviation in raw material indicators, formula compatibility or production processes will trigger finished product failure. Overseas brands are familiar with supporting parameters of local imported raw materials but lack awareness of physicochemical characteristics and compatibility weaknesses of domestic peptides. Blind replication of European formulas for production is highly likely to trigger mass technical accidents;
2. Insights for Raw Material Manufacturers: Most domestic peptide manufacturers only focus on purity control of raw material synthesis, lacking downstream formula R&D capabilities. They can only provide raw material test reports and fail to predict compatibility risks in end-product compounding. To deeply penetrate the European and American mid-to-high-end raw material market, modified stabilized grades must be developed in parallel with supporting downstream formula technical guidance;
3. Technical Takeaways for Copper Tripeptide-1: Copper ions in blue copper peptide feature extremely high activity. Four core risk factors include pH, temperature, reducing agents and ionic thickeners. Generic bulk formulas cannot be adopted for mid-to-high-end customized raw materials, which require buffer and encapsulation modification from the raw material end to adapt to complex compound efficacy systems;
4. Formula Optimization Logic Takeaways: Two solution paths exist to resolve blue copper peptide discoloration and gel breakage: raw material modification (pre-encapsulation) and formula auxiliary material replacement (VC/thickener substitution). HiSiaddi adopted a dual-solution parallel model to meet two client demands: retaining the original formula framework and low-cost auxiliary material replacement, adapting to product iteration demands of mid-to-high-end brands;
5. Production Process Takeaways: Blue copper peptide is heat and light sensitive. Low-temperature feeding and light-shielded production are core requirements for mass production. Most production failures stem from habitual high-temperature feeding for ordinary raw materials, and standardized SOP guidance is mandatory for successful mass production delivery;
6. Core Value Takeaways for HiSiaddi as a Foreign Trade Service Provider: As a neutral third party, HiSiaddi bridges technical information barriers between upstream raw material manufacturers and downstream overseas formula application clients. It supervises directional raw material modification by manufacturers while assisting clients in optimizing terminal formulas and production processes, acting as a core technical link for domestic peptides to successfully enter European and American mid-to-high-end supply chains.
For more formula optimization consulting services, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
